Parallax Volatility Advisers, L.P. Kal Vista Pharmaceuticals, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 35,000 shares of KALV stock, worth $340,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,000Holding current value
$340,900% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding KALV
# of Institutions
131Shares Held
53.3MCall Options Held
63.5KPut Options Held
36.6K-
Vr Adviser, LLC New York, NY6.25MShares$60.9 Million8.73% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$47.9 Million1.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$47.7 Million3.11% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$47.6 Million2.48% of portfolio
-
Vestal Point Capital, LP New York, NY4.77MShares$46.5 Million2.4% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $240M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...